Tag: Vcare PharmaTech

Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel

SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing,...

Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval

NANJING, China, June 5, 2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors....

- A word from our sponsors -

HomeTagsVcare PharmaTech

/C O R R E C T I O N — Sazerac/

WRD and the City of Torrance Break Ground on the Torrance Groundwater Desalter Expansion Project

NEMESIA SARL ANNOUNCES RECEIPT OF DISTRIBUTION IN KIND OF SHARES OF LunR ROYALTIES CORP. FROM LUNDIN GOLD INC.

Tag: Vcare PharmaTech

Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel

Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval

Explore

Press Releases

News & Opinion

Living

Others

Follow us